From discovery to commercialization
Helping life sciences companies bring innovative therapies to patients faster through real-world clinico-genomic data.
Get in touchDriving population genomics for research, clinical, and commercial impact
Helix provides a scalable genomics research platform to conduct large-scale genetic analyses on deeply phenotyped, recontactable individuals. Our proprietary clinico-genomic database of Exome+® sequencing data and deep phenotypic data can be used to accelerate efforts across the drug development lifecycle from discovery to commercialization.

What we do
Target identification & validation
- Identification of promising targets and biomarkers for drug candidates
- Validation of candidates of interest in custom cohorts and independent dataset(s)
Large-scale patient
identification
.
- Patient identification at scale for hard-to-diagnose hereditary diseases
- Genotype-first or phenotype-first approaches to patient identification / referral with full recontactability
Real-world evidence generation
- Use of real-world epidemiology data and analytics for market access and pricing discussions
- Longitudinal monitoring for label expansion studies
Enabling genomic research at a scale and
depth not previously possible

Versatile Exome+® assay
Go beyond GWAS
Panel-grade clinical exome provides the performance of a targeted panel, the breadth of a microarray, and the completeness of an exome — all from one assay

Powerful analytical tools
Get started quickly
Researchers can get started quickly and write code using familiar tools on Helix-hosted infrastructure with no ongoing maintenance

Rapidly scalable infrastructure
Expand in real-time
Frequent updates for incremental samples reduces time to population-scale analyses

Industry-leading privacy and security
Security first
Segregation and encryption of personal and genetic information with strict limitations on access protects the privacy of individual data